University of Memphis
Memphis, Tennessee, US
The University of Memphis is a public research university founded in 1912 in Memphis, Tennessee. Designated as a Carnegie R1 institution, it serves a diverse urban region and leverages the city’s strengths in logistics, healthcare, and the arts. The university is known for research in earthquake science, intelligent systems, and engineering, as well as community-engaged scholarship.
The University of Memphis is an R1 public research university with strengths spanning engineering, earth sciences, cognitive science, public health, and business. Signature units include the FedEx Institute of Technology, the Center for Earthquake Research and Information focused on the New Madrid Seismic Zone, and the Institute for Intelligent Systems working at the intersection of AI, learning, and cognitive modeling. Faculty secure competitive funding from agencies such as the National Science Foundation, National Institutes of Health, and Department of Defense, alongside partnerships with regional industry. The University of Memphis Research Foundation and UMRF Research Park facilitate technology transfer, startup formation, and corporate collaborations. Application domains where the university is particularly active include logistics and supply chain, seismic hazard assessment, cybersecurity, intelligent tutoring and learning technologies, health analytics, and advanced manufacturing.Top industry applications
Halo AI analyzes publication data from OpenAlex to identify which industry applications have the highest concentration of publishing faculty at this institution. It also incorporates applications self-identified by faculty.
Medicine
Medical diagnostics
University of Memphis researchers are developing AI-powered diagnostic tools that interpret histopathology, radiology, and ocular images to detect cancer, stroke, and degenerative diseases earlier and more accurately. They are also validating liquid biopsy assays that track circulating tumor DNA to guide real-time treatment decisions in lung cancer and other solid tumors. These technologies address critical clinical needs for faster, non-invasive diagnostics and precision medicine workflows.Medicine
Pharmaceuticals and drug delivery
University of Memphis researchers develop nanoscale drug carriers—liposomes, electrospun membranes, and polymeric nanoparticles—to target cancer, infections, and chronic diseases with controlled release. They combine these delivery systems with AI-driven drug discovery and clinical trials of novel kinase inhibitors and neuroprotective compounds. The work bridges critical gaps in precision medicine and offers direct pathways for biopharma commercialization and medtech partnerships.Relevant Innovators
YG
Yuan Gao
Principal Investigator
Oncology & cancer therapeuticsOncology & cancer therapeuticsPharmaceuticals and drug deliveryPharmaceuticals and drug delivery
Oncology & cancer therapeuticsOncology & cancer therapeuticsPharmaceuticals and drug deliveryPharmaceuticals and drug deliveryAbby L. Parrill
Unclaimed
Oncology & cancer therapeuticsPharmaceuticals and drug delivery
Oncology & cancer therapeuticsPharmaceuticals and drug deliveryMadhusudhan Alle
Unclaimed
Medical diagnosticsOncology & cancer therapeuticsPharmaceuticals and drug delivery
Medical diagnosticsOncology & cancer therapeuticsPharmaceuticals and drug deliveryMedicine
Oncology & cancer therapeutics
University of Memphis researchers are pioneering precision oncology platforms that use circulating tumor DNA and comprehensive genomic profiling to guide lung cancer treatment decisions and monitor therapeutic response in real time. They are also developing novel small-molecule inhibitors, molecular glue degraders, and natural phytochemical strategies to attack resistant breast, pancreatic, and neuroendocrine tumors. Together, these diagnostic and therapeutic innovations address unmet clinical needs in early detection, personalized therapy selection, and survivorship—opening clear pathways for commercialization in liquid biopsy, targeted drug development, and clinical decision-support.Personal health
Digital health applications
University of Memphis researchers are developing wearable biosensors, smartphone-enabled home diagnostics, and mobile health apps that deliver real-time, personalized interventions for chronic disease management, stress, and smoking cessation. Their telemedicine platforms and AI-driven coaching tools target underserved populations, addressing health equity gaps while reducing care costs. These innovations meet growing commercial demand for accessible remote monitoring and consumer-centric digital therapeutics that improve patient engagement and outcomes.Relevant Innovators
SK
Santosh Kumar
Digital health applicationsStress management systems
Digital health applicationsStress management systemsSatish Kedia
Unclaimed
Digital health applications
Digital health applicationsXiaolei Huang
Unclaimed
Digital health applicationsMedical diagnostics
Digital health applicationsMedical diagnosticsMedicine
Regenerative medicine
University of Memphis scientists develop electrospun scaffolds, placental powders, and conductive aerogels to regenerate skin, bone, and nerve tissue. Their work targets chronic diabetic wounds, traumatic injuries, and musculoskeletal defects with implantable platforms that integrate controlled drug delivery. These biomaterial innovations offer commercial-ready solutions for advanced wound dressings, vascular grafts, and orthopedic therapies with strong market potential.Relevant Innovators
JJ
Jessica Jennings
Principal Investigator
Infectious disease & antimicrobialsOral careRegenerative medicine
Infectious disease & antimicrobialsOral careRegenerative medicineGB
Gary L. Bowlin
Principal Investigator
Regenerative medicine
Regenerative medicineOS
Omar Skalli
Principal Investigator
Regenerative medicine
Regenerative medicineEnergy & natural resources
Energy storage systems
University of Memphis researchers develop advanced nanomaterials including MXenes and metal-oxide composites to boost supercapacitor and battery performance. They also tackle system-level challenges by modeling lithium-ion thermal runaway hazards and optimizing controls for hybrid energy storage in electric vehicle microgrids. This integrated approach delivers safer, more cost-effective energy storage solutions for utilities, remote communities, and behind-the-meter applications.Personal health
Mental wellness solutions
University of Memphis researchers are validating digital therapeutics and brief cognitive behavioral interventions that reduce suicidal behavior in primary care and treat PTSD and substance use among veterans. Their teams also pair wearable biosensors with large language models and just-in-time adaptive technology to create personalized, real-time stress management and smoking cessation tools. Together, these efforts translate evidence-based mental health care into scalable, tech-enabled products that meet rising industry demand for accessible, continuous behavioral health support.Relevant Innovators
Medicine
Infectious disease & antimicrobials
University of Memphis researchers are combating antimicrobial resistance with novel bioactive wound dressings, anti-biofilm implant coatings, and rapid point-of-care diagnostics that target drug-resistant infections in hospitals and agricultural supply chains. They are simultaneously advancing HIV prevention and care through same-day PrEP programs, rapid antiretroviral therapy toolkits, and community testing strategies tailored to high-burden populations in the Southern United States. These efforts translate into clear commercial opportunities for medical device coatings, diagnostic assays, and scalable public health interventions that address urgent infectious disease challenges.Relevant Innovators
Daniel L. Baker
Unclaimed
Infectious disease & antimicrobialsPharmaceuticals and drug delivery
Infectious disease & antimicrobialsPharmaceuticals and drug deliveryFanta D. Gutema
Unclaimed
Food safety and quality controlInfectious disease & antimicrobials
Food safety and quality controlInfectious disease & antimicrobialsLori M. Ward
Unclaimed
Consumer at-home diagnosticsInfectious disease & antimicrobials
Consumer at-home diagnosticsInfectious disease & antimicrobialsLast updated by Halo AI Feb 6, 2026. Please verify key information.
OpenAlex
OpenAlexFor general inquiries
IS
Ido Sarig
Director, Technology Commercialization, University of Memphis
Have a specific need?
Post a free request to University of Memphis faculty.
Post a free request to University of Memphis faculty.
Top industry applications
Medical diagnosticsPharmaceuticals and drug deliveryOncology & cancer therapeuticsDigital health applicationsRegenerative medicineEnergy storage systemsMental wellness solutionsInfectious disease & antimicrobials
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.